"FDA Probes Surprising Side Effects of Diabetes Drugs, Including Hair Loss and Suicidal Thoughts"

The FDA is investigating reports of serious side effects, including hair loss, suicidal thoughts, and airway obstruction, in patients using GLP-1 receptor agonists like Ozempic and Mounjaro, which are diabetes and weight loss drugs. While these drugs are known for their benefits in stimulating insulin secretion and reducing appetite, the potential new risks are not currently listed as side effects. Novo Nordisk, the manufacturer, acknowledges the FDA's review but stands by the safety and efficacy of its products when used as directed.